Professional Summary

Professional Overview

Kenneth Bodmer is a seasoned finance executive with over 20 years of experience in the healthcare and pharmaceutical industries. As the Chief Financial Officer at Prime Therapeutics, he is responsible for overseeing the company's financial operations, strategic planning, and driving financial growth and profitability.

Experience Summary

Current Role

As the Chief Financial Officer at Prime Therapeutics, Kenneth is responsible for managing the company's financial strategy, operations, and reporting. He plays a crucial role in aligning the organization's financial goals with its overall business objectives, ensuring efficient resource allocation and prudent financial decision-making.

Career Progression

Prior to his current role, Kenneth held several senior finance positions, including CFO and EVP of Finance and Administration at Wellpartner, Inc., VP Trade Finance and GM and VP of Wellpartner 340b Services at CVS Health, and SVP Segment Market Finance at Catamaran. He has demonstrated a strong track record of driving financial improvements, optimizing operational efficiency, and spearheading strategic initiatives that have positively impacted the organizations he has served.

Academic Background

Kenneth holds a Bachelor's degree in Accounting from the University of Nebraska-Lincoln, where he graduated with distinction. He is a Certified Public Accountant (CPA) and has completed advanced finance and leadership programs, further enhancing his expertise in financial management and strategic decision-making.

Areas of Expertise

• Financial planning and analysis

• Budgeting and forecasting

• Financial reporting and controls

• Treasury management

• Mergers and acquisitions

• Healthcare and pharmaceutical industry expertise

• Strategic financial leadership

• Operational optimization

Professional Impact

Throughout his career, Kenneth has been recognized for his ability to drive financial improvements, streamline operations, and implement effective cost-saving measures. He has played a pivotal role in several successful acquisitions and integration initiatives, demonstrating his strategic financial acumen and cross-functional collaboration skills.

Conclusion

With his extensive experience in the healthcare and pharmaceutical industries, coupled with his strong financial expertise and strategic leadership, Kenneth Bodmer is poised to continue making a significant impact as the Chief Financial Officer at Prime Therapeutics. His proven track record of financial management, operational optimization, and strategic decision-making positions him as a valuable asset to the organization.